• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肝病的姑息治疗与医院再入院情况

Palliative medicine and hospital readmissions in end-stage liver disease.

作者信息

Rush Barret, Fruhstofer Clark, Walley Keith R, Celi Leo Anthony, Brahmania Mayur

机构信息

Division of Critical Care Medicine, Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada

Department of Medicine, University of British Columbia, Vancouver, Canada.

出版信息

BMJ Support Palliat Care. 2019 Feb 13. doi: 10.1136/bmjspcare-2018-001635.

DOI:10.1136/bmjspcare-2018-001635
PMID:30760459
Abstract

BACKGROUND

Patients with end-stage liver disease (ESLD) have a reduced life expectancy and a significant symptom burden. Our aim is to determine if inpatient palliative care (PC) referral for patients with ESLD is associated with decreased hospital readmission rates.

METHODS

The 2013 US Nationwide Readmission Database (NRD) was used for the current analysis. The NRD allows for longitudinal analysis of all patient hospital admissions across 22 states. Patients ≥18 years of age with a diagnosis of ESLD with at least two decompensating events were included in the analysis. PC referral at the index hospitalisation divided the cohort into two groups, which were tracked for 9 months.

RESULTS

A total of 14 325 172 hospital admissions from the 2013 NRD were examined. In the first 3 months of 2013, a total of 3647 patients with ESLD were admitted with 206 (5.6%) receiving PC referral during the index admission. After the index hospitalisation, patients referred to PC were more likely to be discharged to skilled nursing facilities (45.5% vs 14.7%; p<0.01) or hospice/home care (32.9% vs 15.3%; p<0.01). After propensity score matching, those patients referred to PC demonstrated a significantly lower rate of 1-year hospital readmission (11.0% vs 32.1%; p<0.01).

CONCLUSION

Inpatient PC referral for patients with ESLD was associated with lower rates of hospital readmission. Early concurrent PC referral likely has added beneficial effects beyond quality of life issues and symptom management.

摘要

背景

终末期肝病(ESLD)患者预期寿命缩短,症状负担沉重。我们的目的是确定ESLD患者住院姑息治疗(PC)转诊是否与降低医院再入院率相关。

方法

本次分析使用了2013年美国全国再入院数据库(NRD)。NRD允许对22个州所有患者的住院情况进行纵向分析。分析纳入了年龄≥18岁、诊断为ESLD且至少有两次失代偿事件的患者。在首次住院时进行PC转诊将队列分为两组,并对其进行9个月的跟踪。

结果

共检查了2013年NRD中的14325172例住院病例。在2013年的前3个月,共有3647例ESLD患者入院,其中206例(5.6%)在首次住院期间接受了PC转诊。首次住院后,转诊至PC的患者更有可能被转至专业护理机构(45.5%对14.7%;p<0.01)或临终关怀/家庭护理机构(32.9%对15.3%;p<0.01)。倾向评分匹配后,转诊至PC的患者1年再入院率显著较低(11.0%对32.1%;p<0.01)。

结论

ESLD患者住院PC转诊与较低的医院再入院率相关。早期同时进行PC转诊可能除了对生活质量问题和症状管理外还有额外的有益效果。

相似文献

1
Palliative medicine and hospital readmissions in end-stage liver disease.终末期肝病的姑息治疗与医院再入院情况
BMJ Support Palliat Care. 2019 Feb 13. doi: 10.1136/bmjspcare-2018-001635.
2
Inpatient palliative care referral and 9-month hospital readmission in patients with congestive heart failure: a linked nationwide analysis.充血性心力衰竭患者的住院姑息治疗转介和 9 个月内医院再入院:一项全国范围内的关联分析。
J Intern Med. 2017 Nov;282(5):445-451. doi: 10.1111/joim.12657. Epub 2017 Sep 15.
3
Early palliative care referral may improve end-of-life care in end-stage liver disease patients: A retrospective analysis from a non-transplant center.早期姑息治疗转介可能改善终末期肝病患者的临终关怀:来自非移植中心的回顾性分析。
Am J Med Sci. 2024 Jan;367(1):35-40. doi: 10.1016/j.amjms.2023.10.006. Epub 2023 Nov 3.
4
Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease.终末期肝病患者接受姑息治疗会诊的情况不理想,可能会导致再入院率和费用增加。
J Palliat Med. 2020 Jan;23(1):97-106. doi: 10.1089/jpm.2019.0100. Epub 2019 Aug 9.
5
Palliative care access for hospitalized patients with end-stage liver disease across the United States.美国终末期肝病住院患者的姑息治疗机会。
Hepatology. 2017 Nov;66(5):1585-1591. doi: 10.1002/hep.29297. Epub 2017 Sep 26.
6
A retrospective study on use of palliative care for patients with alcohol related end stage liver disease in United States.一项关于美国酒精性终末期肝病患者姑息治疗使用情况的回顾性研究。
World J Hepatol. 2022 Sep 27;14(9):1817-1829. doi: 10.4254/wjh.v14.i9.1817.
7
Patient and Caregiver Perspectives on Palliative Care in End-Stage Liver Disease.终末期肝病患者和照护者对姑息治疗的看法。
J Palliat Med. 2021 May;24(5):719-724. doi: 10.1089/jpm.2020.0551. Epub 2020 Sep 30.
8
Rate of and Factors Associated with Palliative Care Referral among Patients Declined for Liver Transplantation.被拒绝进行肝移植患者的姑息治疗转介率及相关因素。
J Palliat Med. 2022 Sep;25(9):1404-1408. doi: 10.1089/jpm.2021.0403. Epub 2022 Mar 25.
9
A Pilot Study of a Palliative Care Service Embedded in a Hepatology Clinic at a Large Public Hospital.一项在大型公立医院肝病诊所中嵌入姑息治疗服务的初步研究。
J Palliat Med. 2023 Jun;26(6):776-783. doi: 10.1089/jpm.2022.0438. Epub 2022 Dec 26.
10
The Impact of Obesity in End of Life Care in Patients With End Stage Liver Disease: An Observational Study.肥胖对终末期肝病患者生命终末期关怀的影响:一项观察性研究。
Am J Hosp Palliat Care. 2021 Oct;38(10):1177-1181. doi: 10.1177/1049909120978768. Epub 2020 Dec 7.

引用本文的文献

1
Symptom burden in end-stage liver disease: a prospective cohort study of the symptoms experienced by patients and the role of palliative care.终末期肝病的症状负担:一项关于患者所经历症状及姑息治疗作用的前瞻性队列研究
Therap Adv Gastroenterol. 2025 Jul 13;18:17562848251353624. doi: 10.1177/17562848251353624. eCollection 2025.
2
Palliative Care in Advanced Liver Disease: Similar or Different Palliative Care Needs in Patients with a Prospect of Transplantation? Prospective Study from a Portuguese University Hospital and Transplantation Center.晚期肝病的姑息治疗:有望接受移植的患者的姑息治疗需求是否相似或不同?来自葡萄牙一家大学医院和移植中心的前瞻性研究。
GE Port J Gastroenterol. 2023 Jun 8;30(3):204-212. doi: 10.1159/000522172. eCollection 2023 Jun.
3
A retrospective study on use of palliative care for patients with alcohol related end stage liver disease in United States.一项关于美国酒精性终末期肝病患者姑息治疗使用情况的回顾性研究。
World J Hepatol. 2022 Sep 27;14(9):1817-1829. doi: 10.4254/wjh.v14.i9.1817.
4
Quality of end-of-life care with non-malignant liver disease: Analysis of the VOICES National Survey of Bereaved People.非恶性肝脏疾病患者的临终关怀质量:VOICES 全国遗属调查分析。
Liver Int. 2023 Feb;43(2):308-316. doi: 10.1111/liv.15428. Epub 2022 Sep 22.
5
Reducing readmissions in patients with cirrhosis: the time to act is now.降低肝硬化患者的再入院率:现在是行动的时候了。
Ann Transl Med. 2021 Nov;9(22):1637. doi: 10.21037/atm-21-5270.
6
Developing Priorities for Palliative Care Research in Advanced Liver Disease: A Multidisciplinary Approach.制定晚期肝病姑息治疗研究的优先事项:一种多学科方法。
Hepatol Commun. 2021 Sep;5(9):1469-1480. doi: 10.1002/hep4.1743. Epub 2021 Jun 16.
7
Impact of Palliative Care Services on Treatment and Resource Utilization for Hepatorenal Syndrome in the United States.姑息治疗服务对美国肝肾综合征治疗及资源利用的影响
Medicines (Basel). 2021 May 12;8(5):21. doi: 10.3390/medicines8050021.
8
Health Care Utilization and End-of-Life Care Outcomes for Patients With Decompensated Cirrhosis Based on Transplant Candidacy.基于移植候选资格的失代偿性肝硬化患者的医疗保健利用和临终关怀结局。
J Pain Symptom Manage. 2020 Mar;59(3):590-598. doi: 10.1016/j.jpainsymman.2019.10.016. Epub 2019 Oct 23.